Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on July 28, 2025
NKGen Biotech Presents Troculeucel Mechanism of Action with Corresponding Phase 1 Biomarker Data at the Alzheimer’s Association International Conference 2025
GlobeNewswire
·
July 28, 2025
Troculeucel, a cryopreserved autologous, non-genetically modified NK cell product, appears to cross the blood brain barrier (BBB) via CXCR3, to reduce neuroinflammation via a simple IV administration. Troculeucel was shown to internalize and digest amyloid …
IMUNON Announces Stock Dividend Boosting Shareholder Value
GlobeNewswire
·
July 28, 2025
Stock Dividend Reflects Company’s Confidence in its Phase 3 Study, Long-term Growth Potential, and Dedication to Shareholders LAWRENCEVILLE, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 …
Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025
GlobeNewswire
·
July 28, 2025
Management to host conference call on Thursday, August 7, 2025, at 8:00 am EDT FLORHAM PARK, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel …
ProQR Announces Upcoming Presentation at RNA Editing Summit
GlobeNewswire
·
July 28, 2025
LEIDEN, Netherlands …
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
GlobeNewswire
·
July 28, 2025
Lu177-B7H3 monoclonal antibody is first in class targeted radiopharmaceutical in development against the 4lg subtype of B7-H3 On track to initiate first-in-human study of RV-01 in solid tumors in 4Q25 SYDNEY, July 28, 2025 (GLOBE NEWSWIRE) -- Radiopharm …
Changes in Nokia Corporation's own shares
GlobeNewswire
·
July 28, 2025
Nokia Corporation Stock Exchange Release 28 July 2025 at 15:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 325 584 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia …
Muutokset Nokia Oyj:n omien osakkeiden omistuksessa
GlobeNewswire
·
July 28, 2025
Nokia Oyj Pörssitiedote 28.7.2025 klo 15.00 Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 325 584 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin …
Deliverect Partners with FreedomPay to Transform Payment Operations for Restaurant Chains
GlobeNewswire
·
July 28, 2025
Philadelphia, PA, July 28, 2025 (GLOBE NEWSWIRE) -- Deliverect, a leading global food tech SaaS company, announces a strategic worldwide partnership with FreedomPay, an innovative leader in Next Level Commerce™. The new partnership will provide white- …
Apyx Medical Corporation Announces Launch of Renuvion® in China
GlobeNewswire
·
July 28, 2025
Strong clinical interest and early procedures completed Entered into distribution agreement with GlamMoon, a division of BeauCare Clinics Investment Co., Ltd. post-initial market clearance CLEARWATER, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Apyx Medical …
Guardforce AI Implements Smart Solutions and AI Applications in Thailand
GlobeNewswire
·
July 28, 2025
NEW YORK, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited (Nasdaq: GFAI, GFAIW) (“Guardforce AI” or the “Company”), a global integrated security solutions provider specializing in secured logistics, AI, and Robot-as-a-Service (RaaS), today …
Soleno Therapeutics to Report Second Quarter 2025 Financial Results on August 6, 2025, at 4:30 PM ET
GlobeNewswire
·
July 28, 2025
REDWOOD CITY, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will report its second …
Synchronoss Technologies Announces Second Quarter 2025 Earnings Call Date
GlobeNewswire
·
July 28, 2025
BRIDGEWATER, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, will hold a conference call on Monday, August 11, 2025 at 4:30 p. …
CEA Industries and 10X Capital, with the support of YZi Labs, announce $500 Million Private Placement to Establish Largest Publicly-Listed $BNB Treasury Company in the World (NASDAQ:VAPE)
GlobeNewswire
·
July 28, 2025
Upsized PIPE offering with potential to deliver up to $1.25 billion of gross proceeds Offering consists of a common equity PIPE delivering $500M in gross proceeds ($400M in cash and $100M in Crypto), plus up to $750M in cash which may be received from …
STMicroelectronics Announces Status of Common Share Repurchase Program
GlobeNewswire
·
July 28, 2025
STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from July 21, 2025 to July 25, 2025 AMSTERDAM – July 28, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a …
Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy
GlobeNewswire
·
July 28, 2025
Increases total holdings to 1,535,772 HYPE Company to host investor webinar on Tuesday, July 29th at 2:00pm ET LAGUNA HILLS, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced …
Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results
GlobeNewswire
·
July 28, 2025
SOMERSET, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Monday, August 11, 2025, to review second-quarter 2025 …
Acumen Pharmaceuticals Presents Studies Showing the Utility of a pTau217 Assay in Screening for a Phase 2 Alzheimer’s Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer’s Association International Conference (AAIC) 2025
GlobeNewswire
·
July 28, 2025
NEWTON, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s …
Vertex Report: U.S. Sees Continued Acceleration in Sales Tax Rates and Rules Changes
GlobeNewswire
·
July 28, 2025
KING OF PRUSSIA, Pa., July 28, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today released its 2025 Mid-Year U.S. Rates and Rules Report. The findings indicate that 408 …
Chiesi Global Rare Diseases Spotlights the Profound Impact of Epidermolysis Bullosa in the Film “Living Between Pain and Hope” as part of “The Next Frontier,” a New Series Presented by the Biotechnology Innovation Organization
GlobeNewswire
·
July 28, 2025
BOSTON, July 28, 2025 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases (Chiesi) proudly shares its contribution to the thought-provoking film "Living Between Pain and Hope," as part of “The Next Frontier,” a series presented by the Biotechnology Innovation …
UroGen Announces Publication of Phase 3b Study Results Demonstrating the Feasibility of Home Instillation of ZUSDURI™ for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer in Reviews in Urology
GlobeNewswire
·
July 28, 2025
PRINCETON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative treatments for urothelial and specialty cancers, today announced the publication in Reviews in …